Indomethacin Therapy in Premature Infants with Patent Ductus Arteriosus
Abstract
Indomethacin has been shown to be effectil'e in closing patent ductus arteriosus (PDA) in premature infants. Indomethacin admin.istration decreased the need for assisted ventilation and surgical closure of PDA. Six premature neonates with birth weight less than 2500 gm diagnosed clinically as PDA were given indomethacin. The drug was given as a single dose by mouth or nasogaYtric tube in 2 or 3 consecutlve days. The dose in the first two days was 0.1 mg/kg BW and the last dose (If necessary) was- 0.3 mg/kg BW. Closure of PDA was observed in all six cases. This experience in the use of indomethacin in PDA indicates a need for a further study of the effect of indomethacin in PDA.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Accepted 2017-08-24
Published 1982-04-30
